29 March 2016 - Deborah Wilkes
Archived
Valeant Pharmaceuticals International is seeking a new chief executive officer to replace Michael Pearson. The news comes less than a month after the troubled pharmaceutical company said Pearson had returned to the post following his recovery from a severe case of pneumonia.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.